about
Immune response and immunopathology during toxoplasmosisToxoplasma gondii and schizophreniaIn vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondiiRemarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondiiNonionic block copolymers potentiate activities of drugs for treatment of infections with Toxoplasma gondiiRifapentine is active in vitro and in vivo against Toxoplasma gondiiTrovafloxacin is active against Toxoplasma gondiiImmune responses and resistance to Toxoplasma gondii in mice immunized with antigens of the parasite incorporated into immunostimulating complexes.Trafficking of immune cells in the central nervous systemOcular toxoplasmosis in AIDS patientsPreventing secondary infections among HIV-positive persons.Toxoplasma on the brain: understanding host-pathogen interactions in chronic CNS infection.Opportunistic infections in HIV-infected patients.Treatment of acute experimental toxoplasmosis with investigational poloxamersSynergistic activity of azithromycin and gamma interferon in murine toxoplasmosisDepletion of L3T4+ (CD4+) T lymphocytes prevents development of resistance to Toxoplasma gondii in mice.Detection of specific immunoglobulin E in patients with toxoplasmosisSpecificity and usefulness of an IgE immunosorbent agglutination assay for toxoplasmosis.Improved diagnosis of reactivated toxoplasmosis.An ounce of prevention - The new wave in HIV therapy.
P2860
Q24612341-CA9474B9-D99C-45FE-8995-26D57A081E76Q24629337-2F86FB0D-54D0-4C8E-ACCB-96C09A6337B6Q28320236-E8E68C73-9A17-4CCC-A91F-1285CAD5CD85Q28335576-449E1D63-5739-475E-83A4-4A42E40BDBBEQ28378795-AF6C0143-E2B9-49DA-B7CB-AD878E43DAFBQ28378988-5A517676-2428-42CF-87C6-67205CA095E3Q28379193-CDAD9332-1272-4482-B895-354D80BC8811Q33600932-01E64B49-33D4-4B3F-B0C6-148D38CB505DQ33815795-40605A94-16D9-4AF6-8C80-B6F5A8FACAE7Q34164395-D94549FF-4758-46E0-BB98-4BD14B2A9C3FQ35055557-806BF303-1861-4C3C-8694-AB006C0FCF1FQ35876115-E7D44E08-F5C8-413A-9873-986E480BD906Q35893214-70505345-4675-4B33-B55A-1291102C1FE9Q35899606-2772AED5-E650-44CB-80B6-B356A79D955DQ36754621-29D73CE1-2026-4AF7-969A-456295920A95Q36962970-192F45C4-58E2-48E6-AB58-DEFB60CA3879Q37187607-1FC0B3B9-51BF-44A6-A141-42691D34BBFBQ37255291-FAD7E1D0-4404-4193-ADF1-231AE0C3B217Q40794473-C3166F72-16BD-48D3-8144-A90A33261BA4Q42074149-09ACF8AC-0BB3-4377-8217-B4292724E4D7
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Toxoplasmic encephalitis in patients with AIDS.
@en
Toxoplasmic encephalitis in patients with AIDS.
@nl
type
label
Toxoplasmic encephalitis in patients with AIDS.
@en
Toxoplasmic encephalitis in patients with AIDS.
@nl
prefLabel
Toxoplasmic encephalitis in patients with AIDS.
@en
Toxoplasmic encephalitis in patients with AIDS.
@nl
P1476
Toxoplasmic encephalitis in patients with AIDS.
@en
P2093
Israelski DM
Remington JS
P304
P577
1988-06-01T00:00:00Z